CureVac Inc. (NASDAQ: CVAC) stock rises during pre-market. Here’s what’s happening?

MRAI Stock

CureVac Inc. (NASDAQ: CVAC) stock declined by 7.16% at last close whereas the CVAC stock price gains by 8.44% in the pre-market trading session. CureVac is a multinational biopharmaceutical corporation specializing in messenger RNA (mRNA) technology. CVAC has more than 20 years of experience designing and refining the versatile biological molecule for medical applications. CureVac’s […]

Evofem Biosciences, Inc. (EVFM) stock rises over 14% Pre-Market: Why is it so?

DBGI Stock

Evofem Biosciences, Inc. (EVFM), a biopharmaceutical company, announced its first-quarter 2021 financial results after which the EVFM stock price saw a push of 14.75% to reach $1.40 a share as of this writing. Evofem stock was gloomy during the previous trading session and went down by 5.43% at closing. Let’s briefly analyze the financial results […]

Stamps.com Inc, (NASDAQ: STMP) stock slumped in the premarket trading session; here’s why

XRTX

At last check, in the premarket trading session, Stamps.com Inc. (STMP) shares plunged by -9.17% to $175.0. STMP stock previously closed session at $192.66. The STMP stock volume traded 0.35 million shares, while average 3-month trading volume is 340.49K. Everything you need to know about Stamps.com’s company background Stamps.com Inc. provides is a mailing and […]

Datadog Inc. (NASDAQ: DDOG) stock inclines during pre-market after releasing financial results

EBIX Stock

Datadog Inc. (NASDAQ: DDOG) stock declined by 7.01% whereas the DDOG stock gains by 6.22% in the pre-market session after Datadog announced its first-quarter 2021 financial results. Datadog is a cloud service management and protection platform. The DDOG SaaS platform combines and automates infrastructure monitoring, device efficiency monitoring, and log management to offer a single, […]

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) stock falls during after-hour trading. What is going on?

DNAY Stock

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) stock gained by 0.57% at last close whereas the AUPH stock declines by 21.8% in the after-hours trading session after Aurinia Pharmaceuticals has announced its first-quarter 2021 financial results. Aurinia Pharmaceuticals is a highly integrated biopharmaceutical corporation focusing on developing treatments for patients suffering from chronic diseases with a strong […]